Development of non‐ABO RBC alloantibodies in patients undergoing allogeneic HPC transplantation. Is ABO incompatibility a predisposing factor?

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Transfusion

• Publication date

  2001-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/j.1537-2995.2001.41010106.xPMID 11161254
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alloimmunization after blood transfusion in patients with hematologic and oncologic diseases

  1999cited by this paper
• Hemolysis associated with transplantation

  1998cited by this paper
• Severe hemolytic anemia due to multiple red cell alloantibodies after an ABO‐incompatible allogeneic bone marrow transplant

  1998cited by this paper
• Red cell alloantibody development associated with heart and lung transplantation.

  1995cited by this paper
• Low incidence of red cell and HLA antibody formation by bone marrow transplant patients

  1995cited by this paper
• Bone marrow transplantation.

  1994cited by this paper
• The influence of total dose, fractionation, dose rate, and distribution of total body irradiation on bone marrow transplantation.

  1993cited by this paper
• Immune‐Mediated Cytopenia following Bone Marrow Transplantation Case Reports and Review of the Literature

  1992cited by this paper
• Safety of the Antibody Screening Test as the Sole Method of Pretransfusion Testing

  1992cited by this paper
• Hemolysis of transfused group O red blood cells in minor ABO-incompatible unrelated-donor bone marrow transplants in patients receiving cyclosporine without posttransplant methotrexate.

  1992cited by this paper
• Changing trends in allogeneic bone marrow transplantation for leukemia in the 1980s.

  1992cited by this paper
• RISK FACTORS FOR ACUTE GRAFT‐VERSUS‐HOST DISEASE IN HISTOCOMPATIBLE DONOR BONE MARROW TRANSPLANTATION

  1991cited by this paper
• Immunohematologic complications of bone marrow transplantation.

  1991cited by this paper
• Cyclosporine.

  1989cited by this paper
• Drug therapy: cyclosporine

  1989cited by this paper
• IMMUNOHEMATOLOGIC CONSEQUENCES OF MAJOR ABOMISMATCHED BONE MARROW TRANSPLANTATION

  1988cited by this paper
• Rh antibodies against the pretransplant red cells following Rh‐incompatible bone marrow transplantation

  1988cited by this paper
• Red cell alloantibodies produced after bone marrow transplantation

  1987cited by this paper
• Donor-derived red blood cell antibodies and immune hemolysis after allogeneic bone marrow transplantation.

  1986cited by this paper
• Hemolysis in Rh-negative female recipient after Rh-incompatible bone marrow transplantation for chronic myeloid leukemia.

  1986cited by this paper
• Bone marrow transplantation in patients aged 45 years and older.

  1986cited by this paper
• Cyclosporine

  1985cited by this paper
• How does bone-marrow transplantation cure leukaemia?

  1984cited by this paper
• How does bone-marrow transplantation cure leukaemia?

  1984cited by this paper
• Transplantation of ABH incompatible bone marrow: gravity sedimentation of donor marrow

  1984cited by this paper
• Hemotherapy in patients undergoing blood group incompatible bone marrow transplantation

  1983cited by this paper
• Bone marrow transplantation.

  1977cited by this paper
• Optimal Conditions for the Use of Sulphydryl Compounds in Dissociating Red Cell Antibodies

  1976cited by this paper

• Effect of major ABO blood group mismatched HSCT on blood transfusion and clinical outcomes in AA patients

  2025cites this paper
• TRANSFUSION STRATEGY AND ALLO-IMMUNIZATION TO RED BLOOD CELL ANTIGENS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION WITH PARTIAL DONOR/RECIPIENT RH MATCHING.

  2025cites this paper
• Serologic Characteristics and Clinical Significance of Non-ABO Red Blood Cell Antibodies in Hematopoietic Stem Cell Transplant. The BEST Collaborative Study.

  2025cites this paper
• Development of Non-ABO Red Blood Cell Alloantibodies in Patient Undergoing Allogeneic Haematopoietic Stem Cell Transplant

  2024cites this paper
• Immunoserologic and hemotherapy considerations in patients undergoing hematopoietic progenitor cell transplantation

  2021cites this paper
• Transfusion Therapy in Specific Clinical Situations

  2021cites this paper
• Post–hematopoietic stem cell transplantation immune-mediated anemia: a literature review and novel therapeutics

  2021cites this paper
• Transfusion in RhD Mismatch Hematopoietic Stem Cell Transplantation

  2020cites this paper
• [Relevance of antibodies in hematopoietic stem cell transplantation: Antibodies anti-HLA, anti-platelets, anti-granulocytes, anti-erythrocytes and anti-MICA. Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

  2020cites this paper
• Hematopoietic Cell Transplants: Concepts, Controversies, and Future Directions

  2017cites this paper
• An update on ABO incompatible hematopoietic progenitor cell transplantation.

  2016influential citation
• Red Blood Cell Antibodies in Hematology/Oncology Patients: Interpretation of Immunohematologic Tests and Clinical Significance of Detected Antibodies.

  2016cites this paper
• Complex Transfusion Issues in Pediatric Hematopoietic Stem Cell Transplantation.

  2016cites this paper
• Blood Group Incompatibilities and Hemolytic Complications of Hematopoietic Cell Transplantation

  2016cites this paper
• Prevalence of allo- and auto-antibodies in transfused sickle cell disease and cancer patients at Kenyatta National Hospital

  2016cites this paper
• Transfusion indications for patients with cancer.

  2015cites this paper
• Red cell allo- and autoimmunisation in transfused sickle cell and cancer patients in Kenyatta National Hospital, Nairobi, Kenya

  2015cites this paper
• Transfusion support issues in hematopoietic stem cell transplantation.

  2015cites this paper
• Red cell alloimmunisation in oncology patients: A study from eastern India.

  2015cites this paper
• The Influence of Clinical and Biological Factors on Transfusion-Associated Non-ABO Antigen Alloimmunization: Responders, Hyper-Responders, and Non-Responders

  2014cites this paper
• Minor RBC Ab and allo-SCT

  2014cites this paper
• Expression von Blutgruppenantigenen durch humane mesenchymale Stammzellen

  2013cites this paper
• Clinical guide to ABO-incompatible allogeneic stem cell transplantation.

  2013cites this paper
• Rh D alloimmunization in allogeneic HSCT

  2013cites this paper
• Red‐blood‐cell alloimmunization and number of red‐blood‐cell transfusions

  2012cites this paper
• Is female sex a risk factor for red blood cell alloimmunization after transfusion? A systematic review.

  2012influential citation
• Red blood cell-incompatible allogeneic hematopoietic progenitor cell transplantation

  2011cites this paper
• Direct antiglobulin test-negative autoimmune hemolytic anemia associated with HLA-haploidentical stem cell transplantation

  2011cites this paper
• Alloimmune response after additional red blood cell antigen challenge in immunized hematooncology patients

  2009cites this paper
• Chapter 39 – Transfusion to Bone Marrow or Solid Organ Transplant Recipients

  2007cites this paper
• Transfusion policy: when to stop the use of extremely rare blood for an allogeneic hematopoietic progenitor cell transplant recipient with a history of red cell alloimmunization

  2007cites this paper
• Red blood cell alloantibodies after transfusion: factors influencing incidence and specificity

  2006cites this paper
• The influence of blood group differences in allogeneic hematopoietic peripheral blood progenitor cell transplantation

  2005cites this paper
• Multiple red cell alloantibodies, including anti‐Dib, after allogeneic ABO‐matched peripheral blood progenitor cell transplantation

  2005cites this paper
• Transient anti rhesus alloantibody produced by graft after non-myeloablative allogeneic stem cell transplant.

  2004cites this paper
• Guidelines for compatibility procedures in blood transfusion laboratories

  2004cites this paper
• Non-ABO red blood cell alloantibodies following allogeneic hematopoietic stem cell transplantation

  2004cites this paper
• Red blood cell support and alloimmunization rate against erythrocyte antigens in patients undergoing hematopoietic stem cell transplantation

  2003cites this paper
• Donor anti‐Jka causing hemolysis in a liver transplant recipient. Transfusion 2002;42:363‐7

  2003cites this paper
• Prophylactic antigen‐matched donor blood for patients with warm autoantibodies: an algorithm for transfusion management

  2002cites this paper
• The Role of ABO Incompatibility in Allogeneic Peripheral Blood Stem Cell Transplant.

  2002cites this paper
• Donor anti‐Jka causing hemolysis in a liver transplant recipient

  2002cites this paper
• Relevance of Blood Group Differences and Antibodies in Allogeneic Stem Cell Transplantation

  2002cites this paper
• PREVALENCE OF RED CELL ALLOANTIBODIES IN MULTI-TRANSFUSED HAEMATOLOGY PATIENTS IN A TERTIARY CARE CENTER

  year unknowncites this paper